Ibaraki, Japan

Hirovuki Sugumi

This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirovuki Sugumi. Retrieved from https://idiyas.com/inventor/hirovuki-sugumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirovuki Sugumi: Innovator in Sulfonamide Compounds

Introduction

Hirovuki Sugumi is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of sulfonamide compounds. His innovative work has led to the creation of a patent that showcases his expertise and creativity in this area.

Latest Patents

Hirovuki Sugumi holds a patent for sulfonamide phenyl substituted compounds. This patent includes pharmacologically acceptable salts and outlines a complex formula involving various substituents. The detailed structure of the compounds includes multiple functional groups, demonstrating the versatility and potential applications of his invention.

Career Highlights

Sugumi is currently associated with Eisai Company, Limited, where he continues to contribute to research and development. His work at Eisai has allowed him to explore new avenues in pharmaceutical chemistry, enhancing the company's portfolio of innovative products.

Collaborations

Hirovuki Sugumi has collaborated with notable coworkers, including Takeshi Nagasu and Kyosuke Kitoh. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing their collective research efforts.

Conclusion

Hirovuki Sugumi's contributions to the field of sulfonamide compounds exemplify his innovative spirit and dedication to advancing pharmaceutical science. His work continues to impact the industry positively, showcasing the importance of collaboration and creativity in research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…